Stocks
Sysmex CorporationSSMXY
PNKHealthcareDiagnostics & Research$11.61-0.46%
Price as of · delayed, not real-time
A global leader in in-vitro diagnostics, this company specializes in hematology analyzers and reagents for clinical testing. Investors monitor its performance due to its strong position in automated blood analysis systems and expansion into molecular diagnostics.
Market Cap: $5.4B52W Range: $8.01-$13.49
Congressional Interest in Sysmex Corporation (SSMXY)
5 members of Congress have disclosed 22 trades in Sysmex Corporation (SSMXY), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 11 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
5
Buys
11
Sells
11
Who in Congress Is Trading SSMXY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-22 | Josh Gottheimer | buy | $1K-$15K |
| 2025-08-21 | Josh Gottheimer | sell | $1K-$15K |
| 2025-04-09 | Josh Gottheimer | sell | $1K-$15K |
| 2024-09-09 | Josh Gottheimer | buy | $1K-$15K |
| 2024-09-09 | Josh Gottheimer | buy | $1K-$15K |
| 2024-09-03 | Josh Gottheimer | buy | $1K-$15K |
| 2024-06-05 | Josh Gottheimer | buy | $1K-$15K |
| 2024-05-06 | Josh Gottheimer | buy | $1K-$15K |
| 2024-05-02 | Josh Gottheimer | buy | $1K-$15K |
| 2024-03-09 | Josh Gottheimer | buy | $1K-$15K |
| 2024-02-05 | Josh Gottheimer | buy | $1K-$15K |
| 2023-07-10 | Daniel Goldman | sell | $15K-$50K |
| 2023-02-27 | Daniel Goldman | sell | $1K-$15K |
| 2021-02-17 | Peter Meijer | sell | $15K-$50K |
| 2021-01-28 | Peter Meijer | sell | $1K-$15K |
| 2020-08-04 | Greg Gianforte | buy | $15K-$50K |
| 2020-01-13 | Greg Gianforte | sell | $15K-$50K |
| 2019-06-24 | Donna Shalala | sell | $1K-$15K |
| 2018-12-21 | Greg Gianforte | buy | $15K-$50K |
| 2018-09-18 | Josh Gottheimer | sell | $1K-$15K |
| 2018-09-12 | Greg Gianforte | sell | $50K-$100K |
| 2018-07-05 | Greg Gianforte | sell | $15K-$50K |